Clinical trials sponsored by University of Maryland, Baltimore

Phase breakdown

Conditions studied

Recruiting trials led by University of Maryland, Baltimore

• Comparing Direct vs Indirect Methods for Cascade Screening
  NCT05348564 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluating Buspirone to Treat Opioid Withdrawal
  NCT05511909 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
  NCT06624839 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Male · 2 locations
• Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
  NCT06691243 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
  NCT06864936 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• GCC 2546- Motion Management
  NCT07398209 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• GammaPod Registry and Quality of Life Nomogram
  NCT03562273 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 4 locations
• Glucose Variability and Cognition in Prediabetes
  NCT04201600 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
  NCT06154278 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
  NCT04401982 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
  NCT06501781 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 88 Years · Sex: All (male and female) · 2 locations
• Pharmacogenetics of Response to GLP1R Agonists
  NCT05071898 · Phase: Phase 1 · Ages: 18 Years to 89 Years · Sex: All (male and female) · 1 location
• Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
  NCT03652428 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
  NCT05450965 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• TERPS Trial for de Novo Oligometastic Prostate Cancer
  NCT05223803 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations
• TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
  NCT04843852 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• TMS for Inhibition Enhancement in Schizophrenia
  NCT06155682 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
  NCT05440214 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The ROle of Compression StocKings in Heart Failure Patients
  NCT06350695 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
  NCT06184126 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• White Matter Plasticity in Schizophrenia
  NCT06641297 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 45 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is University of Maryland, Baltimore recruiting for?

University of Maryland, Baltimore is the lead sponsor of 21 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.